Position in DHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$64,217,140
-$30,277,602 QoQ
Shares Held
338,698
-17.9% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Freestone Grove Partners LP holds $254,069,772 across 12 Diagnostics & Research names. DHR ranks #1 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
338,698 | $64,217,140 | |
| 2 | A |
Agilent Technologies, Inc.
|
474,435 | $54,076,101 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
90,516 | $50,860,035 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
203,851 | $34,764,749 | |
| 5 | QGEN |
Qiagen N.V.
|
661,857 | $26,500,754 | |
| 6 | RDNT |
RadNet, Inc.
|
365,394 | $20,421,870 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,690 | $1,115,126 | |
| 8 | LH |
Labcorp Holdings Inc.
|
3,713 | $990,665 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,217,140 | 338,698 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $94,494,742 | 412,785 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $76,732,832 | 388,442 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $89,233,630 | 435,286 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $75,188,643 | 327,548 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||